The financial playbook of biotech firms is undergoing a transformation. No longer content with traditional
BlackRock, the world’s largest asset management firm, significantly ramped up its Bitcoin-focused investments in Q1
Strategy, formerly known as MicroStrategy, reported a 13.7% year-to-date yield on its vast Bitcoin holdings,
MARA, formerly known as Marathon Digital, has acquired 6,474 Bitcoin through a $1 billion zero-interest